Related references
Note: Only part of the references are listed.YC-1 potentiates the antitumor activity of gefitinib by inhibiting HIF-1α and promoting the endocytic trafficking and degradation of EGFR in gefitinib-resistant non-small-cell lung cancer cells
Hui Hu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2020)
Glioblastoma cancer stem cell biology: Potential theranostic targets
Farzaneh Sharifzad et al.
DRUG RESISTANCE UPDATES (2019)
Curcumin overcome primary gefitinib resistance in non-small-cell lung cancer cells through inducing autophagy-related cell death
Ping Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Role of FoxO Proteins in Cellular Response to Antitumor Agents
Giovanni Luca Beretta et al.
CANCERS (2019)
FoxO-1 contributes to the efficacy of the combination of the XPO1 inhibitor selinexor and cisplatin in ovarian carcinoma preclinical models
Cristina Corno et al.
BIOCHEMICAL PHARMACOLOGY (2018)
FOXO1 Inhibits Tumor Cell Migration via Regulating Cell Surface Morphology in Non-Small Cell Lung Cancer Cells
Zhuo Gao et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
FOXO Signaling Pathways as Therapeutic Targets in Cancer
Mohd Farhan et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2017)
Monitoring and Measuring Autophagy
Saori R. Yoshii et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Cisplatin induces protective autophagy through activation of BECNI in human bladder cancer cells
Ji-Fan Lin et al.
DRUG DESIGN DEVELOPMENT AND THERAPY (2017)
Mevastatin blockade of autolysosome maturation stimulates LBH589-induced cell death in triple-negative breast cancer cells
Zhaohu Lin et al.
Oncotarget (2017)
FoxO1 regulates myocardial glucose oxidation rates via transcriptional control of pyruvate dehydrogenase kinase 4 expression
Keshav Gopal et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2017)
Could drugs inhibiting the mevalonate pathway also target cancer stem cells?
Wirginia Likus et al.
DRUG RESISTANCE UPDATES (2016)
An Autophagic Flux Probe that Releases an Internal Control
Takeshi Kaizuka et al.
MOLECULAR CELL (2016)
Stress-Induced EGFR Trafficking: Mechanisms, Functions, and Therapeutic Implications
Xiaojun Tan et al.
TRENDS IN CELL BIOLOGY (2016)
Cross-validation of survival associated biomarkers in gastric cancer using transcriptomic data of 1,065 patients
A. Marcell Szasz et al.
ONCOTARGET (2016)
EGFR-independent autophagy induction with gefitinib and enhancement of its cytotoxic effect by targeting autophagy with clarithromycin in non-small cell lung cancer cells
Shohei Sugita et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2015)
Inhibition of autophagy using 3-methyladenine increases cisplatin-induced apoptosis by increasing endoplasmic reticulum stress in U251 human glioma cells
Ruijian Zhang et al.
MOLECULAR MEDICINE REPORTS (2015)
Chemotherapy triggers HIF-1-dependent glutathione synthesis and copper chelation that induces the breast cancer stem cell phenotype
Haiquan Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
The natural compound oblongifolin C inhibits autophagic flux and enhances antitumor efficacy of nutrient deprivation
Yuanzhi Lao et al.
AUTOPHAGY (2014)
Differential outcome of MEK1/2 inhibitor-platinum combinations in platinum-sensitive and -resistant ovarian carcinoma cells
Giacomo Cossa et al.
CANCER LETTERS (2014)
EGFR signaling and autophagy dependence for growth, survival, and therapy resistance
Barry Jutten et al.
CELL CYCLE (2014)
Crosstalk between apoptosis, necrosis and autophagy
Vassiliki Nikoletopoulou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2013)
The autophagic inhibitor 3-methyladenine potently stimulates PKA-dependent lipolysis in adipocytes
Bradlee L. Heckmann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
EGFR-Mediated Beclin 1 Phosphorylation in Autophagy Suppression, Tumor Progression, and Tumor Chemoresistance
Yongjie Wei et al.
CELL (2013)
Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer
Yuan-yuan Li et al.
LUNG CANCER (2013)
Induction of Autophagy Is an Early Response to Gefitinib and a Potential Therapeutic Target in Breast Cancer
Wieslawa H. Dragowska et al.
PLOS ONE (2013)
FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway
Jingyi Zhou et al.
AUTOPHAGY (2012)
Annexin A5 stimulates autophagy and inhibits endocytosis
Ghita Ghislat et al.
JOURNAL OF CELL SCIENCE (2012)
Targeting the FOXO1/KLF6 axis regulates EGFR signaling and treatment response
Jaya Sangodkar et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
The Extending Network of FOXO Transcriptional Target Genes
Kristan E. van der Vos et al.
ANTIOXIDANTS & REDOX SIGNALING (2011)
Global Cancer Statistics
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2011)
Blockade of hypoxia-inducible factor-1α by YC-1 attenuates interferon-γ and tumor necrosis factor-α-induced intestinal epithelial barrier dysfunction
Hang Liu et al.
CYTOKINE (2011)
EGFR Tyrosine Kinase Inhibitors Activate Autophagy as a Cytoprotective Response in Human Lung Cancer Cells
Weidong Han et al.
PLOS ONE (2011)
The Epidermal Growth Factor Receptor Antibody Cetuximab Induces Autophagy in Cancer Cells by Downregulating HIF-1α and Bcl-2 and Activating the Beclin 1/hVps34 Complex
Xinqun Li et al.
CANCER RESEARCH (2010)
Discovery of Novel Forkhead Box O1 Inhibitors for Treating Type 2 Diabetes: Improvement of Fasting Glycemia in Diabetic db/db Mice
Takeyuki Nagashima et al.
MOLECULAR PHARMACOLOGY (2010)
Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity
Ying Zhao et al.
NATURE CELL BIOLOGY (2010)
Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer
William Pao et al.
NATURE REVIEWS CANCER (2010)
Autophagy in tumour suppression and promotion
Andreas Brech et al.
MOLECULAR ONCOLOGY (2009)
Anticancer mechanisms of YC-1 in human lung cancer cell line, NCI-H226
Chun-Jen Chen et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3
Shunsuke Kimura et al.
AUTOPHAGY (2007)
Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma
Ravi K. Amaravadi et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Involvement of Foxo transcription factors in angiogenesis and postnatal neovascularization
M Potente et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Versatile pharmacological actions of YC-1: anti-platelet to anticancer
YS Chun et al.
CANCER LETTERS (2004)
Determinants of tumor response and survival with erlotinib in patients with non-small-cell lung cancer
R Pérez-Soler et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
The ins and outs of FoxO shuttling: mechanisms of FoxO translocation and transcriptional regulation
LP van der Heide et al.
BIOCHEMICAL JOURNAL (2004)
Frequent activation of AKT in non-small cell lung carcinomas and preneoplastic bronchial lesions
BR Balsara et al.
CARCINOGENESIS (2004)
Phosphorylation of serine 256 suppresses transactivation by FKHR (FOXO1) by multiple mechanisms - Direct and indirect effects on nuclear/cytoplasmic shuttling and DNA binding
XH Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein
H Tran et al.
SCIENCE (2002)
Share Paper
